1333389-87-9Relevant academic research and scientific papers
Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor
Melancon, Bruce J.,Gogliotti, Rocco D.,Tarr, James C.,Saleh, Sam A.,Chauder, Brian A.,Lebois, Evan P.,Cho, Hyekyung P.,Utley, Thomas J.,Sheffler, Douglas J.,Bridges, Thomas M.,Morrison, Ryan D.,Daniels, J. Scott,Niswender, Colleen M.,Conn, P. Jeffrey,Lindsley, Craig W.,Wood, Michael R.
scheme or table, p. 3467 - 3472 (2012/06/18)
This Letter describes the continued optimization of the MLPCN probe molecule ML071. After introducing numerous cyclic constraints and novel substitutions throughout the parent structure, we produced a number of more highly potent agonists of the M1 mACh receptor. While many novel agonists demonstrated a promising ability to increase soluble APPα release, further characterization indicated they may be functioning as bitopic agonists. These results and the implications of a bitopic mode of action are presented.
